Quanterix Announces Leadership Transition Plan
Key Highlights
- ➤Everett Cunningham steps down as Quanterix president and CEO, effective immediately
- ➤Jim Gute appointed interim president and CEO in addition to chief commercial officer role
- ➤Board begins internal and external search for permanent chief executive
- ➤Quanterix reaffirms 2026 financial outlook provided November 9, 2026
Expert Statements
Everett Cunningham, Former President and CEO of Quanterix
“Leading Quanterix has been a privilege, and I am proud of the progress we made”
Everett Cunningham, Former President and CEO of Quanterix
“I have tremendous confidence in the Company's future and look forward to following its continued success.”
Bill Donnelly, Chair of the Board of Quanterix
“In 2026, we have added significant talent to our leadership team which, together, has reinvigorated our commercial organization, significantly advanced our Alzheimer’s diagnostics business and developed clear strategies for our research tool businesses.”
Bill Donnelly, Chair of the Board of Quanterix
“With several exciting catalysts on the horizon and a strong balance sheet, we believe Quanterix is well positioned to capitalize on the opportunities ahead.”
Bill Donnelly, Chair of the Board of Quanterix
“Jim is highly regarded within Quanterix and, with his experience leading successful commercial teams and designing and implementing solutions to improve performance, he is well equipped to take on the additional role of Interim CEO.”
Bill Donnelly, Chair of the Board of Quanterix
“The Board is confident that Jim has the experience, industry expertise and support necessary to serve the Company effectively in this important role.”
Jim Gute, Chief Commercial Officer and Interim President and CEO of Quanterix
“I am excited to step in as Interim President and CEO of Quanterix during such an important time for the Company.”
Jim Gute, Chief Commercial Officer and Interim President and CEO of Quanterix
“I look forward to working closely with the Board and our senior leadership team to continue to drive the business forward.”
Bill Donnelly, Chair of the Board of Quanterix
“Quanterix has an exceptionally talented team, a differentiated technology platform and significant opportunities to lead the next wave of innovation in advanced disease detection and therapeutic development.”
Bill Donnelly, Chair of the Board of Quanterix
“Under Jim’s leadership, the Company will remain focused on improving commercial execution, accelerating revenue growth and expanding our diagnostics position.”
Bill Donnelly, Chair of the Board of Quanterix
“The Board is committed to ensuring a smooth transition and the continued execution of the Company’s strategy.”
Everett Cunningham Steps Down as President and CEO to Accept Another Opportunity
Jim Gute, Quanterix’s Chief Commercial Officer, Appointed to the Additional Role of Interim President and CEO
Get started
Create a free account to read the full story.
